The generation of a 7
Canine and comparative disease studies will benefit greatly from the recent publication of a high-quality, annotated 7.5Â genome assembly for the domestic dog (LindbladToh et al. 2005) . This key resource has served to increase further the value of the dog as a model for genetic traits, as well as advancing the study of canine diseases in their own right. The restricted gene pool associated with populations of pure-bred dogs has great potential to facilitate identification of novel disease genes by reducing the ''background noise'' caused by the high level of heterogeneity within typical human populations. Comparative studies of human and dog counterparts of the same disease therefore have immense potential for improving the health and welfare of both species through the development of more sophisticated approaches for diagnosis, prognosis, and therapy.
Particular interest in canine and comparative cancer studies has stemmed from recognition that many human and dog tumors share extensive pathophysiological features. Human tumors are widely known to display recurrent chromosome aberrations, many of which are hallmarks of particular tumor subtypes. A proportion of aberrations have been associated with clinical behavior, leading to the identification of key genes involved in tumor initiation and progression (see e.g., Mitelman et al. 2005) . We have demonstrated previously that recurrent chromosome abnormalities are also present in a range of canine tumors and have identified genomic features that appear to be associated with specific tumor subtypes (see e.g., Thomas, Smith, et al. 2003; Thomas et al. 2005; Modiano et al. 2005 Modiano et al. , 2006 . A comparative approach, involving detailed investigation of the nature and distribution of recurrent chromosome abnormalities among human and canine tumors, may provide the additional clues needed to further our understanding of the complex genetic processes involved in tumorigenesis. In order to gain full benefit of the dog genome assembly for cytogenetic studies of canine cancers, it is essential to be able to translate chromosome abnormalities directly into DNA sequence information so that we may elucidate the mechanisms involved in tumor development and develop improved therapies. We present preliminary integration of cytogenetic and genome sequence data for the dog through the molecular cytogenetic anchoring of a low-resolution framework of 275 bacterial artificial chromosome (BAC) clones, spaced uniformly at ;10-Mb intervals throughout the canine genome sequence (version 2.0). We have used this panel of BAC clones to generate 2 important resources for cytogenetic evaluation of canine cancer; 1) 40 chromosome-specific multicolor BAC sets, each with ;10-Mb resolution for direct molecular cytogenetic evaluation of chromosome aberrations in canine tumor cells and 2) a genome-wide microarray containing all 40 chromosomespecific clone sets, which may be used for first pass array comparative genomic hybridization (aCGH) analysis of chromosome aberrations in canine tumors. We demonstrate the application of this new integrated resource by presenting aCGH data from a canine histiocytic tumor followed by aCGH-directed multicolor single-locus probe (SLP) fluorescence in situ hybridization (FISH) analysis of tumor chromosomes. These data illustrate how the nature and distribution of chromosome copy number aberrations (CNAs) within a tumor cell population may be investigated using this resource.
Materials and Methods

Clone Selection
Unless otherwise stated, all clones described in the present study were selected from the CHORI-82 dog BAC library (http://bacpac.chori.org/library.php?id5253; Children's Hospital Oakland Research Institute, Oakland, CA), derived from a female Boxer, and from which the 7.5Â dog genome assembly was constructed . For each of the 39 different chromosomes in the female dog, the BAC paired-end read placements in the genome assembly (version 2.0, May 2005; Lindblad-Toh et al. 2005) were used to identify clones located close to each centromere. Due to the presence of highly repetitive sequences at the centromere that are intractable to genome sequence assembly, the most proximal clone available on each of the dog autosomes was typically located approximately 3 Mb distal to the centromere (mean 3.17 Mb, . From this point, BAC clones were selected from the assembly that mapped at approximately 10-Mb intervals along the length of the genome sequence of each dog chromosome. To ensure that both ends of the available genome assembly sequence data for each chromosome were represented in our cytogenetic panel, the most distal (telomeric) clone available was also selected.
Chromosome Assignment
BAC DNA was isolated from 2.5 ml bacterial cultures of each clone using a Qiagen REAL Prep 96 kit (Qiagen, Valencia, CA). Cytogenetic mapping was performed according to our routine multicolor FISH protocols (Breen et al. 2004) . Briefly, 500 ng of DNA from each BAC clone were labeled in a nick translation reaction to incorporate 1 of 5 spectrally resolvable fluorescent nucleotides, Spectrum Red/Orange/ Green-deoxyuridine triphosphate (dUTP) (Vysis, Downers Grove, IL), diethylaminomethylcoumarin-5-dUTP or Cyanine5-dUTP (Perkin Elmer Life Sciences, Boston, MA). Groups of up to 5 BAC clones assigned at consecutive 10-Mb intervals on the same chromosome were differentially labeled and hybridized simultaneously as described elsewhere (Breen et al. 2004) , beginning with the 5 most proximal clones. For chromosomes represented by more than 5 clones, the most distal clone in the initial reaction was then included as the most proximal clone in the subsequent reaction to provide continuity of probe ordering along the length of the chromosome. Cytogenetic assignments for each clone were made according to the 4#,6-diamidino-2-phenylindole (DAPI)-banded nomenclature of Breen et al. (1999) . Chromosome-specific tiling panels were then designed by pooling all BAC probes for each chromosome and cohybridizing them in a single multiprobe 5-color FISH reaction to tile the chromosome.
Construction of a 10-Mb Resolution Genomic Microarray for CGH Analysis
Clones represented in the 10-Mb BAC set were developed for use as targets on a BAC microarray as described previously . Briefly, BAC DNA was amplified by degenerate oligonucleotide-primed PCR (DOP-PCR) using 3 different degenerate primers in separate reactions, the resulting products were pooled and amplified using a 5# amino-linked PCR primer, and then arrayed in duplicate onto amine-binding slides (CodeLink slides, GE Healthcare, Piscataway, NJ) using a MicroGrid II arrayer (Genomic Solutions, Ann Arbor, MI) as described previously Thomas, Fiegler, et al. 2003; Thomas et al. 2005) . Also included on the array were BAC clones representing dog orthologues of 31 cancer-related genes, of which 25 have been reported previously (Thomas, Bridge, et al. 2003 ) and the remaining 6 (ABL1, BCR, BCL2, NF2, p16/INK4A [also known as CDKN2A], and PTEN) represent new cytogenetic assignments. With 4 exceptions (ABL1, BCR, NF2, and p16/ INK4A from the CHORI-82 library), clones representing cancer genes were derived from the RPCI-81 male dog BAC library (Li et al. 1999 ) and were assigned a location within the dog genome assembly (version 2.0) by aligning BAC end sequence data to the genome using BLAT (Kent 2002) . Due to the absence of CFA Y clones from the female CHORI-82 library, 5 clones previously identified from the RPCI-81 library, and Thomas et al. Genome-Anchored BAC Set and CGH Array for the Domestic Dog assigned to CFA Y by FISH analysis, were also included in the data set . Details of all clones represented on the array are listed as online supplementary data at http:// www.cvm.ncsu.edu/mbs/breen_matthew.htm.
aCGH Analysis aCGH analysis was performed as described previously . First, a ''self-self '' hybridization was performed by differentially labeling and cohybridizing a constitutional DNA sample from a clinically healthy dog onto the 10-Mb array. Subsequently, as an example of the application of this microarray to the study of canine cancer, we performed aCGH analysis of a histiocytic tumor from a female flat-coated retriever (FCR). Tumor DNA was labeled with cyanine3-dCTP (Perkin Elmer) using a BioPrime Array CGH Labeling System (Invitrogen). A sex-mismatched reference sample representing equimolar pools of DNA isolated from the peripheral blood of 10 clinically healthy male FCRs was similarly labeled with cyanine5-dCTP (Perkin Elmer), and aCGH analysis was performed as described previously . A dye-swap analysis was also carried out, where the test and reference samples were labeled with cyanine5-dCTP and cyanine3-dCTP, respectively. Arrays were scanned using a ScanArray 4000 at 10 lm resolution and quantified using ScanArray Express version 3.0 (Perkin Elmer). Each spot position was automatically located, and manual adjustments were made as necessary. Spots with confidence levels ,0.1, and/or with .0.3 standard deviations between replicates, were excluded from further analysis. Fluorescence intensities were calculated for each spot after local background subtraction, block normalized to a median 1:1 ratio on the autosomal clones, and ratios of normalized values established. The mean fluorescence ratio of each replicate was then converted to a log 2 ratio in order to weight chromosomal gains and losses equally and plotted graphically in genomic order. Regions of genomic imbalance were identified using the aCGH-smooth algorithm (Jong et al. 2004) , with threshold limits for gain and loss set at log 2 values equivalent to 1.15:1 (gain) and 0.85:1 (loss) of tumor versus reference ratios, respectively.
Evaluation of Genomic Imbalances by SLP FISH Analysis
Chromosome preparations were generated by direct harvest of tumor cells using conventional techniques of colcemid arrest, hypotonic treatment, and methanol/glacial acetic acid fixation. For consistency, these cells were isolated from the same biopsy specimen from which the tumor DNA was isolated. FISH analysis of chromosome and interphase preparations from the tumor sample was carried out using SLPs representing selected clones from the 10-Mb panel, chosen from regions showing a range of normal and aberrant copy number ratios. Images were acquired from a minimum of 30 representative cells in each instance. The copy number status of each probe was scored by 2 independent investigators with no prior knowledge of the corresponding aCGH data.
Results
Chromosome Assignment of the 10-Mb BAC Set A total of 275 clones, each positioned within the 7.5Â dog genome assembly (version 2.0, Lindblad-Toh et al. 2005) , were selected from the CHORI-82 library to represent a 10-Mb BAC panel spanning all dog autosomes and CFA X. The number of clones per chromosome ranged from 4 (CFA 35, 36, 37, and 38) to 14 (CFA X). An example of the FISH data for the 10-Mb clone set for CFA 1 is shown in Figure 1 , in which all 13 CFA 1 BAC clones have been simultaneously hybridized as a 5-color chromosome-specific tiling set. Based on current genome assembly data, the mean spacing of markers on each chromosome ranged from 7.75 Mb (CFA 38) to 10.63 Mb (CFA 19), with an overall, genome-wide mean of 9.71 Mb. The relative order of clones along each chromosome was consistent with that predicted from the genome assembly, and with few exceptions, the cytogenetic assignment of clones to the 450-band-stage DAPIbanded ideogram of the dog (Breen et al. 1999 ) demonstrated the expected uniform distribution throughout the karyotype. We observed a subset of physical intervals whose size appeared to be inconsistent with that predicted from the sequence assembly. The most extensive example of such a discrepancy is shown in Figure 2 . According to the dog genome assembly, BAC clones 313-K05 and 330-A23 and 330-A23 and 188-A17 (located at the centromeric end of CFA 9) are each separated by intervals of ;10 Mb (10.31 and 9.84 Mb, respectively). FISH mapping of the CFA 9 BAC set showed that the cytogenetic interval between the 2 most proximal of these clones (313-K05 and 330-A23) was significantly greater than the assembly data would imply. Additional discrepant intervals were evident on CFA 3, 4, 8, 10, 11, 26, 27, 28, 30, 32, 35, 36, and Xp (Figure 3) . Allowing for the highly repetitive sequences at chromosome termini, the mapping of clones to the proximal and distal ends of the genome assembly for each chromosome showed excellent cytogenetic coverage of all autosomes, although CFA 12 was remarkable due to underrepresentation of the centromeric band, whereas CFA X was overrepresented near the centromere.
The overall resolution of the clone set was increased by the inclusion of BAC clones representing 31 cancer-associated genes, which were distributed across 20 of the 38 dog autosomes. When combined with the 10-Mb BAC set, the mean spacing of markers throughout CFA 1-CFA X is reduced to 8.77 Mb (ranging from 5.96 Mb on CFA 26 to 10.63 Mb on CFA 19). The 5 clones on CFA Y cannot be integrated into the female genome sequence assembly but are included as part of the genome-wide BAC panel. The total number of clones represented on the array described in the present study is thus 311, each of which has been assigned to a unique chromosomal location by FISH analysis ( Figure  3 ). Six canine cancer-associated genes were newly assigned by FISH analysis in the present study: BCL2 (CFA 1q13.1prox), ABL1 (CFA 9q25dist-q26.1prox), p16/INK4A (CFA 11q15dist-q16prox), NF2 (CFA 26q22), BCR (CFA 26q24), and PTEN (CFA 26q25).
Detection and Investigation of Recurrent Chromosome Aberrations in a Canine Tumor
In contrast to the results of the self-self hybridization ( Figure  4A ), aCGH analysis of DNA isolated from the histiocytic tumor demonstrated the presence of a range of whole and partial chromosome CNAs. Most striking was amplification of a single clone (126-D04) on CFA 20 (Figures 4B and C) . aCGH data indicated whole chromosome copy number increases for CFA 3, CFA 13 (including the regions harboring the KIT and MYC oncogenes), and CFA 37 ( Figure 4B ). Partial chromosome loss was observed for the distal regions of CFA 16 and 23 and also the telomeric end of CFA 26 including the PTEN locus ( Figure 4C ). Numerous less-extensive genomic imbalances were observed throughout the genome.
Chromosome preparations derived from tumor cells ( Figures 5A and B) showed obvious deviations from the normal 2n 5 78 karyotype, including numerous abnormal biarmed structures. SLP analysis was conducted using BAC clones from CFA 20 and 26, representing chromosomes for which the aCGH data indicated the presence of regions of normal, increased, and decreased copy number. SLP analysis showed the expected concordance with aCGH data. Further details are provided in the legend accompanying Figure 5 .
Discussion
We present a 10-Mb resolution panel of cytogenetically assigned BAC clones for use in cytogenetic studies in the domestic dog as a resource that will complement the increasing range of resources available for canine genome analysis. The development of this resource presented an opportunity to The FISH image to the right demonstrates the expected uniform distribution of 5 of the 7 clones along the length of CFA 9. The clear exception is the uneven cytogenetic spacing between markers 313-K06, 330-A23, and 188-A17 near the centromere, resulting from a larger than expected physical distance between the 2 most proximal CFA 9 clones (see main text for details). . Whole-genome aCGH profiles obtained using the 10-Mb assembly-integrated dog BAC array showing composite dyeswapped array CGH profiles of (A) a self-self hybridization of differentially labeled reference DNA and (B) a DNA sample derived from a canine histiocytic tumor cohybridized with reference DNA. Data are plotted as the median, block-normalized, and background-subtracted log 2 ratio of the replicate spots for each BAC clone on the 10-Mb array. Log 2 ratios representing genomic gain and loss are indicated by horizontal bars above (thin green line) and below (thin red line) the midline representing normal copy number. The thick orange line for all chromosomes in (A) shows that the copy number status throughout the genome is reported as normal, as expected for a self-self hybridization. In (B), this chromosome copy number status line appears as either red or green in compare the cytogenetic distribution of an anchored framework of BAC clones positioned uniformly at ;10-Mb intervals throughout the version 2.0 dog genome assembly. Overall, the results indicate that the genome sequence represents excellent cytogenetic coverage (centromere-totelomere) of each dog autosome and the X chromosome. The uniform cytogenetic distribution of most of the chromosome-specific BAC sets also indicates close correlation between cytogenetic and assembly-derived distances. The most significant exception was the centromeric region of CFA 9, which showed uneven clone spacing and which is known to contain highly repetitive sequences (Thomas et al. 2001; Thomas, Smith, et al. 2003) . The challenges associated with constructing contiguous sequence reads at sites of highly repetitive DNA suggest that CFA 9q11.2-q13 may be underrepresented in the dog genome assembly, leading to an underestimation of the physical extent of this region. It is possible that the other deviations from the expected uniform intervals between clones may be attributed to the nucleotide composition and secondary structure of the DNA sequence at those locations. Similar discrepancies have been observed between human cytogenetic maps, chromosome banding patterns, and genome sequence assemblies (for a discussion, see Furey and Haussler 2003) .
Although providing an insight into the physical coverage of the assembly, this cytogenetic resource also advances our ability to characterize chromosome defects and their resulting effects on genome imbalance and structural reorganization through the development of a genomic microarray for CGH analysis. Although cancer directed, the array may be utilized in the evaluation of any condition in which genomic imbalance occurs. This resource represents a key addition to the dog genome analysis ''toolbox'' because with each clone integrated into the dog genome assembly, for the first time we now have the means to translate chromosome aberrations directly into DNA sequence. This is a major advantage to our search for candidate genes involved in genetic diseases and heritable traits in both veterinary and comparative research. We have demonstrated the application of the resource to the study of a canine histiocytic cancer, presenting with a complex karyotype that is typical of this aggressive form of malignancy. Characterization of highly aberrant genomes using classical cytogenetics alone is highly labor intensive, particularly in the case of subtle deviations from the normal karyotype. SLP analysis enables a more rapid and accurate assessment of both structural and numerical abnormalities, but selection of the appropriate probes requires prior knowledge of these defects. aCGH analysis largely overcomes these limitations because it permits a genome-wide assessment of chromosome imbalances that allows targeted selection of SLPs for subsequent assessment of aberrations in individual cells. aCGH analysis with our 10-Mb resolution BAC array indicated the presence of a range of CNAs, both increases and decreases, throughout the genome. Subsequent FISH analysis using BAC probes selected from the arrayed 10-Mb set correlated with the CNA data indicated by aCGH analysis. Furthermore, this combined approach also revealed the chaotic structural organization of the tumor genome, resulting from a range of chromosome breakages and fusions. The most remarkable CNA identified by aCGH was amplification of the region represented by clone 126-D04 (CFA20; 23.12 Mb), consistent with SLP analysis showing all that 30 cells scored contained 6 copies of this locus, distributed across 4 different chromosome structures ( Figure  5C ). The power of the resource described in the present study, however, lies in the ability to readily translate such findings into information with potential biological significance. For example, using the Dog Genome Browser Gateway to interrogate the sequence assembly for this region of CFA 20, (http://genome.ucsc.edu/cgi-bin/hgGateway), we identified a gene, FOXP1, that lies within 1 Mb of the region represented by clone 126-D04. Structural alterations of the FOXP1 transcription factor gene have been described in several human cancers, most notably those of lymphoid origin (Wlodarska et al. 2005) , and have been correlated with both up-and downregulation of the gene product. Increased expression of FOXP1 has been associated with poor survival in human diffuse large B-cell lymphoma (Barrans et al. 2004) but with an improved prognosis in breast carcinomas (Fox et al. 2004) . This suggests that FOXP1 may also act as a useful prognostic aid in canine cancers and is currently undergoing further investigation. The assembly-integrated microarray described here, in association with the genome-wide BAC SLP panel, represents one approach by which the role of both existing and novel candidate genes may be investigated.
The cytogenetic mapping of 6 new dog cancer-associated genes in the present study, making a total of 31 thus far assigned via our studies, further increases the significance of the arrayed clone set for cancer studies. The inclusion of these markers into the integrated clone set revealed that regions where genomic imbalances were apparent (red 5 loss and green 5 gain), as determined by the aCGH Smooth algorithm (Jong et al. 2004 ). The profile indicates whole chromosome gain for CFA 3, CFA 13 (including both MYC and KIT), and CFA 37, with amplification of a clone (126-D04) in the mid region of CFA 20. A decreased copy number was detected for the distal regions of CFA 16 and CFA 23 and the telomeric end of CFA 26, including the PTEN locus. Enlarged aCGH profiles for CFA 20 and CFA 26 are shown in (C) and (D), respectively, on which 5 BAC clones from each chromosome are identified. These clones were differentially labeled and used in subsequent SLP analysis of the histiocytic tumor (see Figure 5 ). On CFA 20, the aCGH profile indicates that 199-B04 and 126-M05 show subtle copy number increase, 126-D04 exhibits amplification, and 313-B12 and 325-G21 have an apparent normal copy number. On CFA 26, the aCGH profile indicates that whereas the first 3 clones have a normal copy number, the 2 most distal clones, 365-P05# and 191-C19, both demonstrate copy number decrease. Figure 5 . aCGH-directed multicolor SLP analysis of a case of canine histiocytic sarcoma. Chromosome preparations were generated from the same tumor biopsy used to isolate the DNA sample from which the aCGH profile in Figure 4B D) show only those chromosomes to which hybridization signals of the SLPs from CFA 20 and CFA 26, respectively, were observed. On the left are the 5 color composite images and to the right are the 5 corresponding single-color planes, organized from left to right according to the order in which these clones map to normal dog chromosomes (from centromere to telomere). The CFA 20 SLP panel (A, C) identified 4 structures containing regions corresponding to this chromosome, each with a different morphology and probe hybridization profile. These 4 structures comprised 2 metacentric chromosomes (labeled i and iii), one submetacentric chromosome (labeled ii) and one small acrocentric chromosome (labeled iv) whose SLP profile was consistent with that of a grossly normal CFA 20, with the exception of a probable deletion between clones 313-B12 and 325-G21. The metacentric chromosome labeled ''i'' showed a complex abnormal hybridization pattern of all 5 CFA 20 probes resulting from several apparent structural as well as numerical a subset of genomic aberrations identified in the histiocytic tumor involved known cancer genes, particularly gains of the MYC and KIT oncogenes that we have described previously as features of several dog cancers, as well as deletions of the tumor-suppressor PTEN (e.g., Dickerson et al. 2005; Thomas, Fiegler, et al. 2003; Thomas et al. 2005 ). The addition of clones representing BCL2, BCR, and ABL1 in this genomewide set has particular relevance for the study of hematological malignancies in which these genes are well known to be involved in cell cycle disregulation via chromosome translocation events (see Mitelman et al. 2005) . With the availability of a high-quality dog genome assembly, the prior challenges involved in identifying dog orthologs of key human genes are now largely negated, and this is likely to have a tremendous impact on advancing canine and comparative disease studies.
Although the inclusion of known cancer-associated genes in the clone panel has obvious implications for studying cancer genome aberrations, perhaps more importantly, the application of this cytogenetic resource to large cohorts of tumor cases will highlight regions of the genome showing chromosomal imbalance that may harbor as-yet unidentified genes involved in the etiology of the malignancy or that may represent targets for novel directed therapies. Through the application and further refinement of the resource described herein, coupled with continued multidisciplinary and comparative studies of canine and human tumors, the scene is set for exciting advancements in our understanding of tumorigenesis in the dog.
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